Fig. 4.
Fig. 4. Antibody blocking of a CHS ear swelling response to DNFB. Mice were treated as described and ears were measured 24 hours after elicitation. (A) Wild-type mice: combined anti-endothelial selectin antibody significantly reduces antigen-specific ear swelling compared with both untreated and anti-CD45RB control treated animals. Antibody to VLA-4 is equally effective, whereas neither anti–L-selectin nor anti-CD44 treatment has any effect. (B) L-selectin–deficient mice: treatment with combined anti-endothelial selectin or anti–VLA-4 significantly reduces ear swelling. Anti-CD44 and control anti-CD45RB have no effect. n ≥ 4 for each treatment group. *P < .001 compared with both untreated and anti-CD45RB control treated animals.

Antibody blocking of a CHS ear swelling response to DNFB. Mice were treated as described and ears were measured 24 hours after elicitation. (A) Wild-type mice: combined anti-endothelial selectin antibody significantly reduces antigen-specific ear swelling compared with both untreated and anti-CD45RB control treated animals. Antibody to VLA-4 is equally effective, whereas neither anti–L-selectin nor anti-CD44 treatment has any effect. (B) L-selectin–deficient mice: treatment with combined anti-endothelial selectin or anti–VLA-4 significantly reduces ear swelling. Anti-CD44 and control anti-CD45RB have no effect. n ≥ 4 for each treatment group. *P < .001 compared with both untreated and anti-CD45RB control treated animals.

Close Modal

or Create an Account

Close Modal
Close Modal